Sarepta Therapeutics

+$1.19 (+1.43%) Today
-$0.29 (-0.34%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

CEO
Douglas S. Ingram
Employees
866
Headquarters
Cambridge, Massachusetts
Founded
1980

SRPT Key Statistics

Market Cap
6.72B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.70M
High Today
$85.75
Low Today
$82.50
Open Price
$83.16
Volume
1.90M
52 Week High
$181.83
52 Week Low
$65.30

SRPT News

Benzinga15h

Expert Ratings For Sarepta Therapeutics - Sarepta Therapeutics

Over the past 3 months, 6 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. These analysts are typically employed by large Wall

SRPT Earnings

-$1.84
-$1.23
-$0.61
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure